Prevnar 13

Prevnar 13 Indications/Uses

vaccine, pneumococcal




Zuellig Pharma
Full Prescribing Info
Adults ≥18 Years: Active immunization for the prevention of pneumococcal disease (including pneumonia and invasive disease) in adults ≥18 years caused by Streptococcus pneumoniae. (See Pharmacology: Pharmacodynamics under Actions and Precautions for information on protection against specific pneumococcal serotypes.)
Infants and Children 6 Weeks to 17 Years: Active immunization for the prevention of invasive disease, pneumonia and acute otitis media caused by Streptococcus pneumoniae in infants, children and adolescents from 6 weeks to 17 years.
The use of Prevnar 13 should be determined on the basis of official recommendations taking into consideration the impact of invasive disease in different age groups, as well as the variability of serotype epidemiology in different geographical areas.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in